Cargando…
Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand?
Patients with longstanding extensive colitis are at an increased risk of developing colorectal cancer (CRC), and are therefore enrolled into colonoscopy screening programmes with the aim of detecting pre‐cancerous dysplastic change. However, current surveillance programs face multiple limitations re...
Autores principales: | Al Bakir, Ibrahim, Kabir, Misha, Yalchin, Mehmet, Hart, Ailsa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752268/ https://www.ncbi.nlm.nih.gov/pubmed/36349435 http://dx.doi.org/10.1002/ueg2.12330 |
Ejemplares similares
-
Multicentre derivation and validation of a colitis-associated colorectal cancer risk prediction web tool
por: Curtius, Kit, et al.
Publicado: (2022) -
Ultrasonography in inflammatory bowel disease – So far we are?
por: Christian, Maaser, et al.
Publicado: (2022) -
Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview
por: Choi, Chang-Ho Ryan, et al.
Publicado: (2015) -
Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study
por: Choi, Chang-Ho Ryan, et al.
Publicado: (2019) -
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022)